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Summary
The mantra of “evidence-based policy” is continuing to gain ground, with 
calls for public policy to be informed by scientific evidence. However, in 
many areas of public policy the role of evidence and science is highly con-
tested. This is amply demonstrated in the area of illegal drugs policy. Illegal 
drugs policy, concerned with governments’ approaches to controlling the sale 
and use of drugs such as heroin, cocaine, and cannabis, is a highly contest-
ed area, and hence a fruitful case example of the complexity of policy. The 
features of illicit drug policy explored in this paper are: government actors, 
which span multiple departments; political ambivalence and multiple stake-
holders outside government; community attitudes and a high media profile. 
These features need to be taken into account in understanding the relationship 
between policy and research evidence. In this context, the role of research 
evidence can be fraught. Examination of a number of current ‘hot topics’ in 
drug policy demonstrates the variety of ways in which evidence is used in 
drug policy processes. 
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Introduction
Evidence-based or evidence-informed policy is a common mantra. Good public 
policy includes consideration of research evidence, but the uptake of evidence in 
policy-making processes is fraught with barriers (Anderson et al., 2005; Brownson, 
Royer, Ewing & McBride, 2006; Edwards, 2005; Gregrich, 2003; Hanney, Gonza-
lez-Block, Buxton & Kogan, 2003; Lomas, 1997; Secker, 1993; Stone, Maxwell & 
Keating, 2001). Barriers from the research perspective include the long timeframe 
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for research; often contradictory or equivocal findings; research questions that are 
not relevant; the absence of any research evidence; and the research environment – 
which does not reward policy relevant activities. From the policy point of view, bar-
riers include the policy environment itself, the short timeframe for decisions, rapid 
change, lack of skills to interpret and use research effectively and poor access to 
research. In my experience, researchers feel frustrated and policy makers feel mis-
understood. “The policy world is as alien to most researchers as a distant foreign 
land and most do not even realise it” (Agar, 2002).
Drug policy is a perfect example of a complex social problem, without obvi-
ous solutions, driven by highly emotional arguments and strong interest groups. It 
is ideal for the study of the role of evidence, inasmuch as evidence is but one input 
into policy.
There are many current debates in drug policy internationally. These include, 
amongst others, law reform: legalisation of use/possession, especially of cannabis; 
injecting rooms; prescribed heroin; goals for drug treatment (abstinence or reduced 
use); and workplace drug testing. Not every country or state is considering these 
policies actively, but many people in society have a view about drugs policy, and 
these topics are frequently raised. How can evidence contribute to these? What 
kinds of evidence contribute? Or are these policy debates less about evidence and 
more about ideology? I will return to this theme at the end.
Illicit Drug Policy: Government Actors
Drug problems are complex and involve physical, social, psychological and com-
munity aspects. For some people, drug problems are seen solely as a criminal jus-
tice problem – drug users should be arrested, and drug traders punished. For others, 
it is firmly a health problem. In the USA, promulgation of “addiction as a disease” 
has seen the growth in treatment interventions and a strong push for the health port-
folios of government to lead the way in drug policy. For example, DuPont et al. (in 
press) state that “the root of the drug problem is found in the human brain, specifi-
cally the brain’s reward centers that control behaviour”. At the same time, the “ad-
diction as a disease” concept has attracted criticism from social scientists, who note 
that drug use is a social phenomenon, and occurs as a consequence of environment, 
social circumstances and so on. In addition, the “addiction as a disease” leaves little 
room for recreational drug use. Recreational drug use is the most common form of 
drug use (only a minority go on to develop a dependence or addiction per se) (Wag-
ner & Anthony, 2002). Yet recreational use can be harmful – and should be the sub-
ject of drug policy as much as “addiction”. 
Taking the broader perspective on drug policy, which is inclusive of health but 
also of social and community aspects, leads to the appreciation that drug policy 
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spans multiple areas of government, notably law enforcement and policing, health, 
community services and education. Table 1 displays the large variety of ‘drug poli-
cies’ within the four pillars of drug policy: Prevention; Treatment; Law enforce-
ment; and Harm reduction (Ritter & McDonald, 2008).
Table 1. Drug Policy Options, Divided by the Four Pillars of Prevention, 
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More than 100 different drug policy options can be readily identified, each of 
which has a variable evidence base (some strong, some weak). There are a number 
of reflections that can be made when drug policy is examined from this perspective 
of multiple policy options. 
Firstly, it demonstrates the requirement for a comprehensive, whole of govern-
ment approach to drug policy. This in itself creates many challenges: government 
departments often operate in silos and certainly in competition with each other for 
limited resources. Thus, if the health system argues that greater investment in health 
responses will lead to reductions in spending within the criminal justice areas, this 
is of little comfort to the health bureaucrats because the savings do not accrue to 
their portfolio. In addition, portfolios can have conflicting goals. For example, at-
tendance by police when an ambulance is called for a drug overdose. The goal of the 
police is to arrest the user; the ambulance officer’s goal is to save the person’s life. 







• Community programs for 
young people
• Crime prevention through 
environmental design 
(CPTED)
• Infancy and early childhood 
programs for at-risk groups
• At-risk family interventions
• At-risk youth programs
• Post-natal support for drug 
dependent mothers
• Parenting skills for drug 
dependent women
• Proactive classroom 
management & school 
policy
• Mentoring and peer support 
programs
• Renewal programs
• Drug Action Teams
• Screening in health settings
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• Police management reform
• Asset forfeiture 
• Financial controls and monitoring 
re: money laundering detection 
and prevention
• Controls on precursor chemicals
• Crime mapping technology
• Multi agency taskforces/
partnerships
• Community policing
• Civil remedies, third party 
policing, drug nuisance abatement
• Police discretion
• Police cautioning programs
• Court programs 
• Restorative justice programs
• Detention of intoxicated drug user
• Neighbourhood Watch groups
• Drug driving programs
• Monitoring of drug use by inmates 
Source: Ritter & McDonald, 2008
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The second observation is that usually one area of government is required to 
provide overall leadership for drug policy. In many countries, including Australia, 
this occurs within “Health”. In most EU countries, this occurs at the President, 
Prime Minister or cross-Ministerial levels (e.g. USA Drug Tsar, Office of Nation-
al Drug Control Program). In Croatia, the ‘Commission for Combating Drugs’ is 
composed of members of all relevant ministries and is chaired by the Deputy Prime 
Minister in charge of social issues and human rights. And in other countries, this 
occurs within the crime and policing portfolios. Notably in South East Asian coun-
tries, responsibility for drugs occurs more often through criminal justice or social 
departments, such as “The Department for Social Evils Prevention” (within the 
Ministry of Labour Invalids and Social Affairs) in Vietnam. Interestingly, there has 
been no documented analysis or research on the impact of where the policy control 
body sits within government. 
Thirdly, returning to the list of possible options, it should be apparent that one 
must rely on a portfolio of strategies, across all the areas, rather than single inter-
ventions. This is consistent with the notion that effective drugs policy must contain 
both a supply reduction element (law enforcement) and a demand reduction ele-
ment (treatment and prevention). Reducing supply without reducing demand for 
drugs will have little influence; likewise reducing demand for drugs without at-
tending to supply will also be limited. This begs the question regarding an appro-
priate “balance” between drug policy elements. Many nations formally state that 
drug policy should entail balanced efforts across multiple domains. For example 
in Australia, one of the aims of the National Drug Strategy is ‘to achieve a balance 
between harm-reduction, demand-reduction and supply-reduction measures to re-
duce the harmful effects of drugs in Australia’ (Ritter, 2010). Similarly, the recent 
American National Drug Control Strategy emphasises a balanced policy of preven-
tion, treatment, law enforcement and international cooperation (Office of National 
Drug Control Policy, 2010). In Switzerland’s four pillar model, balance is seen as ‘a 
pragmatic middle way’, with the Swiss strategy aiming to increase the interchange 
between prevention, treatment, harm reduction and law enforcement (Swiss Con-
federation, 2006). Despite this rhetoric, however, there is little policy analysis of 
how balance can be achieved, or what that ‘balance’ should look like – which is a 
fruitful area for research (Ritter, 2010).
Fourthly, and finally, such a list of possible interventions across four pillars 
tempts the notion of evidence-based policy. Surely the key task for governments 
is to choose from amongst these options those which show the greatest effect for 
the least cost, operate synergistically and minimise unintended consequences. In a 
world where evidence reigns supreme, drug policy would be a rational construction 
from the menu of options, and one which achieves society’s desired goals in the 
most cost-effective manner.
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This technocratic view of drug policy ignores the reality of a policy area where 
there are strong emotions, morality politics are at play and there are not necessarily 
shared goals. The technocratic view of policy processes is infrequently supported 
in other areas of social policy: the role of politics, public opinion, interest groups 
and coincidental ‘opportunities’ have been well documented in the policy literature 
(Kingdon, 2003; Lindblom, 1959, 1979; Ritter & Bammer, 2010; Sabatier, 1988, 
2007; Stone, 2002; Weiss, 1983). Illicit drugs are no exception, and carry symbolic 
significance (Bertram, Blachman, Sharpe & Andreas, 1996; Keane, 2002). We turn 
to these factors next.
Politics of Drug Policy
Characterised on a simple spectrum, the politics of drug policy can be either ‘zero 
tolerance’ or ‘harm reduction’. For the former, drug policy signifies a moral state-
ment by government against drug use and an endeavour to eliminate such “social 
evil” from society, through a zero tolerance or abstentionist position. Drug use must 
be eliminated, those responsible must be punished, and society must be protect-
ed from those (marginalised and stigmatised) individuals. For harm reduction, go-
vernment’s role is to protect society from the consequences of drug use, but not to 
eliminate drug use itself (which is seen as unrealistic). The harm reduction position 
accepts that the majority of people in society use drugs (either once or often, across 
many substances), and that the harmful consequences of such use are the target of 
government policy. In its extreme, legalisation of all drugs would reduce the harm-
fulness of drug use given that arguably many of the harms arising from drug use 
occur as a consequence of its illegality (criminal sanctions, imprisonment, impure 
substances, black market activity, and so on).
Internationally, it is difficult to ascertain where on this simplified spectrum 
drug policy is heading. Three international bodies are responsible for the imple-
mentation of international drug policy: the Commission on Narcotic Drugs (CND), 
the United Nations Office on Drugs and Crime (UNODC), and the International 
Narcotics Control Board (INCB) (Babor et al., 2010). The international bodies are 
clearly abstentionist and the international treaties explicitly note the requirement 
for nations to criminalise drug use and drug trade. These include the United Nations 
Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, 
and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Sub-
stances (United Nations Office on Drugs and Crime, 2010). 
The US has been highly influential in international drug policy and their re-
strictive policy ‘holds sway’. At the same time, there is a groundswell towards de-
criminalisation and in some cases legalisation of cannabis. Portugal’s now famous 
decriminalisation policy (Hughes & Stevens, 2007) has been discussed across the 
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globe as an example. The same goes for the recent Californian referendum (No-
vember 2010) on the legalisation of cannabis, which was narrowly defeated (53.5% 
voting against it). The latter has been subject to policy analysis (Kilmer, Caulkins, 
Pacula, MacCoun & Reuter, 2010), but there are few other examples of such policy 
analysis at the macro level.
This is despite there being notable differences between countries in rates of 
drug use – indeed, there is an ‘objective’ policy measure in this instance (although 
some would argue that rates of use per se are not sensitive to more important vari-
ables, such as extent of harm). By way of example, Figure 1 on the next page pro-
vides lifetime drug use rates in students across 34 countries. As can be seen, drug 
use rates vary greatly across European countries. 
There has been little policy analysis that compares policy stance and drug use 
rates. It has been suggested that the states with stronger welfare policies have lower 
rates of use, but this is not substantiated. (The reverse has also been argued by Du-
Pont [in press].) Policy stance likewise does not obviously distinguish countries. 
And one notes that drug policy has actually been largely stable. For example, in 
the USA, their restrictive drug policy has remained stable since the 1970s despite 
changes in political parties (Democrat vs Republican). This is also true in Australia 
in that both our Liberal and Labour governments have maintained the same drug 
policy since 1985. There does not appear to be a simplistic left-right, conservative-
-progressive divide.
One possibility to account for the ‘stability’ is that drug policy does not have 
any attractive or beneficial aspects for a politician. Putting drug policy on the agen-
da merely identifies a problem – the solutions are not obvious, and any substantial 
shift in direction (from repressive to progressive or vice versa) would entail sub-
stantial effort. Given the global stability in drug use rates (United Nations Office 
on Drugs and Crime, 2009), there appears little in it for a politician. In Australia, 
this appears to be the case. In the last two federal elections (November 2007 and 
August 2010), illicit drugs were not a significant part of the campaigns, and since 
the change in government in 2007 little has been said that could be interpreted as a 
comprehensive policy statement. Rather, the focus has been on alcohol and tobacco, 
which, although timely and to be encouraged, could indicate that the issue of illicit 
drugs has slipped off the agenda (Ritter, Lancaster, Grech & Reuter, 2011). 
The paradox, however, appears to be the central interest by the general pub-
lic in drug policy. Drug policy attracts media, and most of the general public hold 
views about drugs. In the 2008 ‘Public Opinion Towards Governance: Results from 
the Inaugural ANU Poll’ (http://www.anu.edu.au), 2% of Australians thought that 
illicit drugs were the most important issue facing Australia, behind the environment 
(19%), the economy (17%) and jobs (6%). We will now examine public opinion 
more closely.
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Figure 1. Lifetime Use of Any Illicit Drug. Secondary School Students. 2007
1
 5
    6
    6
      7
        8
        8
          9
            10
                    14
                      15
                      15
                      15
                             18
                               19
                                 20
                                 20
                                     22
                                     22
                                     22
                                       23
                                         24
                                         24
                                           25
                                                 28
                                                 28
                                                   29
                                                   29
                                                   29
                                                            33
                                                            33
                                                              34
                                                                      38
                                                                                       46
Ritter, A., The Role of Research Evidence in Drug Policy Development in Australia
149
Public Opinion
The interrelationship between policy and public opinion has been well documented 
(Burstein, 2003; Gonzenbach, 1992; Page & Shapiro, 1983; Stimson, 2004). Pub-
lic opinion on illicit drugs has been the subject of frequent polls – in Australia, the 
general public are surveyed every three years regarding their opinions on a number 
of drug policy questions (Matthew-Simmons, Love & Ritter, 2008). Research has 
shown changing opinions on issues such as cannabis legalisation. For example, 
in 1993 support for cannabis legalisation was 26%, climbing to a high of 34% in 
1998, with subsequent declines to 19% by the year 2007 (Matthew-Simmons et al., 
2008). There has also been a rise in the overall numbers responding that they do not 
know what their opinion is on drug policy issues (Matthew-Simmons et al., 2008). 
In Australia, we can conclude that if policy follows public opinion, then it is highly 
unlikely that governments will move to change the legal status of cannabis; the win-
dow of opportunity for that policy shift appears to have been in the late 1990s and 
is now closing.
More generally, the Australian public opinion research suggests a generally 
conservative shift in attitudes towards a range of drug policy issues (Matthew-Sim-
mons et al., 2008). But the picture is not straightforward. Although support for re-
forms such as cannabis legalisation decreased and support for law enforcement in-
creased, there was also evidence of increased support for harm reduction measures 
such as needle syringe programs and safe injecting centres (Matthew-Simmons et 
al., 2008). This suggests that polarised political debate is unlikely to resonate with 
the community at large. McKnight (2005) argues that the left-right ideological di-
vide is increasingly irrelevant for many issues in Australian politics, and that Aus-
tralian society will increasingly prefer for policy to be judged on its own merits. The 
trend in public opinion in relation to drug issues would suggest that this might be 
the case for this policy arena, as much as any other.
Media Influence
The role of the media in shaping public opinion and political debate is also signifi-
cant (see for example Fan, 1996). The media can define public interest by setting 
the agenda and frame issues through selection and salience (Lancaster, Hughes, 
Spicer, Matthew-Simmons & Dillon, 2010). The media can build consensus about 
which issues are most important and the associated solutions (McCombs, 1997; 
McCombs & Shaw, 1972). This can then feed into political debate and decision 
making. This has implications for many aspects of illicit drug policy.
There have been a small number of studies in Australia examining the influ-
ence of the media in relation to illicit drug policy. In a study of press coverage 
of a proposed heroin trial, it was found that dominant media portrayals of heroin 
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users as ‘deviants’ presented by opponents of the trial played a significant role in the 
political demise of the heroin trial (Elliott & Chapman, 2000). Likewise, Lawrence 
et al. (2000) suggested that it was the substantial negative coverage by selected 
media outlets which ultimately influenced the final policy decision not to proceed 
with the trial. There are also positive examples of the role of the media in shaping 
public attitudes to drug issues. For example, McArthur (1999) noted the shift in 
media coverage regarding the efficacy of methadone treatment in the 1980s which 
contributed to greater community understanding of the benefits from treatment in 
reducing crime.
Media portrayals of drug issues over a 6 year period (2003 to 2008) in Australia 
revealed that the dominant media portrayals concerned law enforcement or criminal 
justice action (Hughes et al., 2010). This is despite the strong government focus on 
health responses and an overarching framework of harm minimisation. 
Interestingly, the media analysis research also found that most articles were re-
ported in a neutral manner, in the absence of crisis framings (Hughes et al., 2010). 
The ‘neutrality’ of the media drug portrayals (at least in Australia) is consistent with 
illicit drugs not being on the political agenda, and the overall stability of illicit drugs 
policy. This suggestion is complemented by the public opinion data (in Australia) 
demonstrating increasing rates of ‘don’t know’ responses, coupled with the lack of 
a consistent ‘ideology’ amongst respondents. This seems to suggest an environment 
where evidence-based policy may have some traction, given that issues which have 
very high emotional content tend to attract greater contest regarding the evidence. 
Where does evidence-based drug policy sit given this context?
Evidence-based Drug Policy?
Alas, despite this somewhat promising analysis, the role of evidence in drug policy 
remains limited. On a broad level, we can certainly say that evidence competes with 
other information, and then competes with interest groups and ideology (Weiss, 
1983). Likewise, ‘advocacy coalitions’ may use research evidence, notably in pro-
fessional forums (Sabatier, 1988). In Kingdon’s multiple streams model of policy 
processes, research plays a central role in the policy stream, where new solutions 
are explored (Kingdon, 2003). Perhaps most frequently, however, policy change 
occurs in a series of small incremental shifts (Lindblom, 1959, 1979) where deci-
sion makers are choosing between marginal improvements. These can frequently be 
informed by research evidence. In each of these theoretical frameworks for policy, 
case studies of research evidence being used to inform illicit drug policy have been 
identified (Ritter & Bammer, 2010).
As a first step, however, decision makers need to access research. Even if we 
think that policy processes are complicated and that research only plays a minor 
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role, we still need to know how to get research onto the desks of decision makers, so 
that it can at least be considered within the mix. Ritter (2009) surveyed Australian 
government drug policy makers (across health and police government portfolios) 
and asked them to nominate the sources of research evidence that informed their 
most recent policy decision.
In every case, the policy maker contacted someone who they regarded as ‘ex-
pert’ and asked for advice. Interestingly, the expert was not necessarily an expert on 
the topic at hand, but someone trusted and available. In addition, all the respondents 
said that they looked for some reference, in their office, that they could use (Ritter, 
2009). This speaks to the value of having readily available technical reports that the 
policy maker can take down and rapidly consult as required. The third most com-
mon source was ‘google’ – not ‘google scholar’ or particular academic sites, but 
simply ‘google’. It should be remembered that many policy makers do not have ac-
cess to academic libraries, journals and so on, so they rely on whatever they can find 
rapidly and without cost/subscription. Reassuringly, in Australia at least, more than 
half the policy makers referred to statistical data in making their most recent deci-
sion. Finally, less than half consulted academic literature (35%; Ritter, 2009). There 
were a number of comments made about the use of academic literature: it is diffi-
cult to source, it is highly specific to a particular topic, and one can frequently find 
an alternate paper that will contradict the one one wishes to cite. This last point is 
important: policy makers need research to stand by the decision, but they also need 
it not to be refutable. Academic publishing is concerned with publishing refutable 
pieces, or refuting pieces of work. This is an inherent problem for policy makers.
The ways in which research can be taken up and used has been most exten-
sively examined by Carol Weiss and colleagues (Weiss, 1979, 1977; Weiss, Mur-
phy-Graham & Birkeland, 2005). In her typology, there are three primary ways in 
which research is used: instrumentally, politically/symbolically, and conceptually. 
The instrumental view is akin to an engineering model, where research gives direc-
tion to policy, and research findings lead to action. This is the usual interpretation, 
but is arguably the most uncommon use of research. In political/symbolic utilisa-
tion, research is used to support or justify pre-existing preferences or actions or to 
justify delay. It has primarily a legitimating function and offers proof of responsive-
ness. The conceptual use of research is also termed ‘enlightenment’. In this delayed 
and indirect research usage, research contributes to percolation of new ideas and 
concepts which over time become ‘common knowledge’ and contribute to the over-
all knowledge endeavour rather than any one specific policy decision. (Weiss also 
notes two further uses: imposed/mandated use; and ignored entirely.) A systematic 
approach to understanding the extent of research utilisation by policy makers would 
be to examine Weiss’ research utilisation typology as it applied to specific pieces 
of research.
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Conclusions
I have argued that a whole of government approach is required across multiple go-
vernment actors; that politics influences drug policy, but there has been a level of 
stability in drug policy that belies its emotive content; that public opinion on drug 
policy is less driven by coherent ideology, and more by pragmatic responses; and 
that decision makers rarely access academic literature and use research in instru-
mental and symbolic ways.
To return to the current debates listed at the start of this paper: how can evi-
dence contribute to these? And what kinds of evidence contribute? It is striking 
that in the case of some of the topics, research evidence is either completely absent 
or marginal to the question. This applies to legalisation of drugs. As noted earlier, 
there is a slowly growing group of studies on cannabis legalisation, but these are 
most commonly conducted by advocates who have already established a position 
(with RAND’s work being a notable exception). In the case of prescribed heroin, 
however, we have a very strong evidence-base demonstrating efficacy (Oviedo-
-Joekes, Brissette, Marsh et al., 2009) without subsequent policy uptake, at least in 
Australia. It may be the case that the results of the heroin trials conducted elsewhere 
have not been accessible to decision makers given their reliance on non-academic 
research sources. Perhaps more importantly, however, this is an example of where 
politics and interest groups play a more substantial role than the evidence base per 
se. This is certainly the case in the Australian injecting room debate (Van Beek, 
2004). This suggests that evidence is a necessary but insufficient requirement for 
policy, and in some instances what is required is strong community support, posi-
tive public opinion, and media uptake.
On topics such as suitable goals for drug treatment (abstinence versus reduced 
use), research evidence can contribute data on outcomes (e.g. DuPont & Hum-
phries, 2011), but it cannot resolve what is essentially a moral or ideological ques-
tion. This requires engaged public debate. Similarly, workplace drug testing has 
both proponents and opponents. Research may contribute with better technology, 
but ultimately it is a question of values. These two examples (along with human 
rights drug policy and harm reduction) highlight the importance of policy processes 
over and above research evidence. 
Finally, one obvious gap in our research evidence has to do with policy re-
search. Throughout this paper, I identify numerous issues that would benefit from 
close examination. They include: the extent to which restrictive or progressive re-
gimes have different rates of drug use; analysis of the impact of where the policy 
control body sits within government; exploring notions of ‘balanced’ drug policy; 
comparisons of how other policy makers access research evidence when making de-
cisions; and, of course, more research on the topics of interest in drug policy, such 
as legalisation. 
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